CATS: A Center for Adaptive Optics Treasury Survey of Distant Galaxies
David C. Koo(University of California, Santa Cruz), Mark Chun(University of Hawaii at Hilo), S. Wright(University of California San Diego), S. Perlmutter(Lawrence Berkeley National Laboratory), M. Barczys(University of California, Los Angeles), C. E. Max, Eric Steinbring(Herzberg Institute of Astrophysics), J. Melbourne(California Institute of Technology), James Larkin(Trinity College Dublin), A. J. Metevier(Sonoma State University)
AAS
June 1, 2006
Cited by 0
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Pembrolizumab versus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2015|5.9k
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2019|3.7k
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
|New England Journal of Medicine|2017|2.2k
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
|New England Journal of Medicine|2014|2k